Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

For the quarter ended March 31, 2025, Zydus Wellness reported 17% year-on-year growth in net sales at ₹9,106 million, up from ₹7,780 million in Q4 FY24. Adjusted net profit after tax for the quarter was ₹1,719 million, an increase of 14.4% over the previous year. Quarterly EBITDA grew 17.1%, from ₹1,622 million to ₹1,900 million.

The company attributed its performance to continued marketing investments and the strong momentum of key brands including Nutralite, Glucon-D, Everyuth, and Nycil. The Food and Nutrition segment posted a quarterly growth of 15.4% and annual growth of 13% in FY25.

Following its 100% acquisition of Naturell (India) Private Limited, the newly integrated business is performing as expected.

Key brand performance during the year reflected continued market leadership across categories. The Sugar Free brand maintained its dominant position in the sugar substitute segment with a market share of 95.9%, reaffirming its leadership status. Similarly, Glucon-D retained its number one rank in its category, holding a market share of 58.8% at the MAT level.

While the overall Nutrition Drink category registered a decline of 2.1%* at the MAT level, Complan maintained its presence with a 4%* market share. Meanwhile, the company continued to strengthen and diversify its Nutralite product portfolio, building on innovation and distribution.

The Personal Care segment showed strong momentum with consistent double-digit growth. For Q4, the segment grew by 22.5%, while the full-year growth stood at 33.4%. Within this, Nycil remained the market leader in the prickly heat powder category with a share of 33.8%. Everyuth Scrub also sustained its leadership position, increasing its market share to 48.5%, a rise of 321.4 basis points compared to the same period last year.

The Everyuth brand further expanded into new segments with the launch of Sheet Masks in three variants—Golden Glow, Anti-Pollution, and Aloe Cucumber. Everyuth Peel Off continued to dominate its category with a 77.7%* share, reflecting a growth of 6.1 basis points. In the broader facial cleansing segment, Everyuth was ranked fifth with a 7.7%* market share.

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore